Cylite

What Cylite does

Cylite is commercializing Hyperparallel OCT, a proprietary optical coherence tomography platform targeted at the ophthalmology and optometry sectors. The company was founded in 2013 and is headquartered in Notting Hill, Australia, operating as a private for-profit entity with 11-50 employees. Its core technology centers on a parallelized OCT architecture intended to enable three-dimensional volumetric measurement of the eye, differentiating the platform from conventional scanning OCT instruments used in eye-care clinics.

The founding team comprises Steven Frisken (co-founder, CEO and board member), Grant Frisken (co-founder and CTO), and Simon Poole (co-founder and VP Business Development), suggesting a technically-led organization rooted in optical engineering expertise. The company has secured one recorded funding round in September 2019 led by Main Sequence Ventures, although the capital amount was not disclosed in the available data.

The company's business model, pricing structure, and GTM motion are not detailed in the source data. The corporate website (cyliteoptics.com) currently displays only a verification/placeholder page, with no disclosed customers, channel partnerships, pricing, regulatory clearances, or unit volumes. This points to a pre-commercial or early-pilot commercialization stage, typical of medical-device instrumentation firms navigating clinical validation and regulatory pathways before scaling clinician-channel sales.

Name

Cylite

Website

https://cyliteoptics.com

Company type

Private

Founded year

2013

Headcount range

11–50 employees

Short description

Cylite is commercializing Hyperparallel OCT, a proprietary parallelized optical coherence tomography platform for advanced 3D measurement of the eye, targeting ophthalmology and optometry clinicians.

Ownership category

akta.pro rank

Headquarters

HQ city

Notting Hill

HQ country

Australia

HQ region

Oceania

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales

Core offering

Cylite is commercialising Hyperparallel OCT, a proprietary optical coherence tomography technology platform designed to perform high-precision measurements in ophthalmology and optometry. The offering targets eye-care clinicians, researchers, and instrumentation OEMs with a parallelised OCT architecture intended to improve the speed, resolution, and volumetric capability of ocular measurements compared with conventional OCT systems.

Differentiator

Problem solved

Functional benefit

Products and services

• Hyperparallel OCT platform A proprietary optical coherence tomography platform for ophthalmology and optometry that uses parallelised acquisition to perform high-precision, volumetric ocular measurements for clinicians and vision researchers.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Expansion highlights2 records

Emerging players

• Wasatch Photonics: Wasatch Photonics develops swept-source OCT engines and modules used in ophthalmic and industrial imaging. It is comparable to Cylite at the photonics component/subsystem level, supplying or competing for the same OCT system integrators.
• Optopol Technology: Optopol is a Polish manufacturer of spectral-domain OCT systems and perimeters for ophthalmology. It is an emerging direct competitor targeting similar clinical OCT use cases as Cylite, particularly in European markets.

Broad incumbents

• Carl Zeiss Meditec (ZEISS Ophthalmology): ZEISS offers the CIRRUS line of OCT systems alongside a broad ophthalmic surgical and diagnostic portfolio. It is a broad incumbent serving cataract, refractive, and retinal specialists globally with extensive clinical validation and installed base.
• Topcon Healthcare: Topcon manufactures OCT systems (Maestro2, Triton) and is a broad ophthalmic equipment incumbent with strong distribution in optometry channels. It is comparable to Cylite in selling OCT to optometrists and ophthalmologists worldwide.
• NIDEK: NIDEK manufactures a broad range of ophthalmic diagnostic devices including OCT systems (Mirante). It serves eye care practitioners globally and is a relevant incumbent competitor in the ophthalmic imaging equipment market where Cylite competes.
• Canon Medical (Ophthalmic): Canon offers OCT systems (Xephilio OCT-S1) using swept-source technology as part of a wider ophthalmic and imaging portfolio. It competes with Cylite in the advanced/next-generation OCT segment for clinical specialists.

Direct peers

• Heidelberg Engineering: Heidelberg Engineering is a leading manufacturer of OCT and confocal laser imaging systems for ophthalmology (SPECTRALIS platform). It is the closest direct competitor to Cylite, serving retinal specialists and ophthalmology clinics globally with premium diagnostic OCT systems.
• Optovue (Visionix): Optovue pioneered OCT angiography (OCTA) and is now part of Visionix. It is a direct competitor focused on advanced OCT and OCTA for optometry and ophthalmology, mirroring Cylite's clinical positioning in next-generation retinal imaging.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Customer concentration

• Xx.com/cyliteoptics

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cylite